GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
688117 ChengDu Sheng Nuo Biotec
- 23.42
- -0.05-0.21%
Market Closed Jan 24 15:00 CST
2.63BMarket Cap28.46P/E (TTM)
23.72High22.88Low16.09KlotVolume23.47Open23.47Pre Close37.40MTurnover1.43%Turnover Ratio37.41P/E (Static)112.42MShares36.9852wk High2.85P/B2.63BFloat Cap16.2652wk Low28.16Limit Up112.42MShs Float57.26Historical High18.78Limit Down3.58%Amplitude14.38Historical Low0.20Dividend TTM23.25Avg Price8.97KlotAsk0.85%Div YieldTTM100Lot Size6.47KlotBid
ChengDu Sheng Nuo Biotec News
Shengnuo Biotech: Report of Minsheng Securities Co., Ltd. on Chengdu Shengnuo Biotechnology Co., Ltd.\'s continuous supervision and regular on-site inspection in 2024
Report of Minsheng Securities Co., Ltd. on the 2024 continuous supervision and regular on-site inspection report of Chengdu Shengnuo Biotechnology Co., Ltd.
Shengnuo Biotech: Announcement of Resolutions of the 23rd Meeting of the 4th Board of Supervisors
Shengnuo Biotech: Announcement on the Company and Actual Controllers Providing Guarantees for Wholly-owned Subsidiaries to Apply for Comprehensive Bank Credit Lines
Shengnuo Biotech: Minsheng Securities Co., Ltd.\'s inspection opinion on Chengdu Shengnuo Biotechnology Co., Ltd. and the actual controller providing guarantees for wholly-owned subsidiaries to apply for comprehensive bank credit lines
Shengnuo Biotech: Articles of Association (December 2024)
Shengnuo Biopharmaceutical Co., Ltd.: Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Minsheng Securities Co., Ltd.\'s inspection opinion on Chengdu Shengnuo Biotechnology Co., Ltd. and the actual controller providing guarantees for wholly-owned subsidiaries to apply for comprehensive bank credit lines
Articles of Association (December 2024)
Announcement of Resolutions of the 23rd Meeting of the Fourth Board of Supervisors
Announcement on holding the results briefing for the third quarter of 2024
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024
Shengnuo Biotech: Announcement on increasing the amount of daily related transactions expected in 2024
Shengnuo Biopharmaceutical Co., Ltd.: Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Shengnuo Biotech: Announcement on the company increasing the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Shengnuo Biotech: Minsheng Securities Co., Ltd.\'s inspection opinion on the extension of some fund-raising investment projects of Chengdu Shengnuo Biotechnology Co., Ltd.
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for a wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Shengnuo Biotech: Announcement of Resolutions of the 22nd Meeting of the 4th Board of Supervisors
Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024